The Immediate Preoperative Anastrozole, Tamoxifen, or Combined With Tamoxifen (IMPACT) trial was designed to test the hypothesis that the clinical and/or biologic effects of neoadjuvant tamoxifen ...
A new study published in The Lancet Oncology discusses the efficacy of anastrozole, a molecule used to prevent breast cancer in postmenopausal women with a high risk of breast cancer. Study: Effect of ...
A drug previously used to treat breast cancer is now being offered to high risk women as a preventative measure. It has previously been used to treat breast cancer but has been “repurposed” to prevent ...
We recruited consecutive postmenopausal women, age ≥ 18 years, with hormone-sensitive nonmetastatic breast cancer who were prescribed anastrozole at least 3 months before enrollment. Each completed a ...
London [UK], January 22 (ANI): A study by researchers from Queen Mary University of London shows that bone loss known to be associated with the use of the breast cancer prevention drug Anastrozole ...
The news that the U.K. has approved a preventive drug for post-menopausal women at risk of developing breast cancer wasn’t a shock to breast medical oncologist Abenaa Brewster. But the fact that a ...
A long-time family friend had to decide whether to undergo five years of antiestrogen therapy following surgery and radiation for her breast cancer. The odds were high that she would be OK without the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback